UAB Medicine’s Leadership Development Office (LDO) honored 33 graduates of the Emerging Leaders Series (ELS) fall 2025 Cohort 4 during a ceremony held on Thursday, Nov. 12. The cohort completed a multi-session program designed to strengthen leadership capability for emerging leaders across the enterprise.

A rare fungal sinus infection that used to affect mostly people in tropical countries is now showing up in the Southeastern United States, and doctors are learning how to better recognize and treat it thanks to new research from UAB.

You may be eligible to participate in a research study led by UAB Pediatrics. Babies typically receive four doses of the pneumococcal vaccine at 2, 4, 6, and about 12 months of age to help protect against infections such as ear infections, sinus infections, pneumonia, bacteremia (blood infection), and meningitis.

Chronic granulomatous fungal sinusitis is a rare, debilitating infection characterized by an enlarged mass in the nasal cavity or sinuses, facial pain and swelling, eye bulging, vision problems, headache and nasal congestion.

The Alabama Vaccine Research Clinic (AVRC) at UAB is seeking healthy adults ages 18 to 65 to take part in a national HIV prevention study. This Phase 2 clinical trial is testing the safety and potential benefits of three investigational monoclonal antibodies—lab-made proteins that may help the body block HIV.

The Blazer Bridge Fund encourages discovery among the UAB community by providing financial support to innovative ideas and inventions.

These new findings help simplify the treatment for patients with syphilis.

T-bet expression is required for persistence of memory B cells that have rapid differentiation potential to become antibody-producing plasma cells in response to a second infection.

The UAB Medicine Institute for Leadership, the flagship program of the UAB Medicine Leadership Development Office, recently celebrated the graduation of its 10th cohort.

The Cassell Family Bidirectional Training Program—empowered by the generous support of Ralph Cassell, Dr. Gail Cassell, and Dr.

Infectious Diseases faculty Bobbie Van Der Pol, Ph.D., MPH, and Olivia Van Gerwen, M.D., MPH, were recognized by the American Sexually Transmitted Diseases Association for their outstanding contributions to the field.

The UAB Marnix E. Heersink School of Medicine recognized 15 faculty members for their outstanding contributions to research, education, and clinical care at the Spring 2025 Endowed Chairs and Professorships Reception.

The UAB Heersink School of Medicine is proud to announce the 19 winners of the 2025 Dean's Excellence Awards for Faculty.

Rena C. Patel, M.D., MPH, MPhil, has been named associate director for Global Health Research for the UAB Mary Heersink Institute for Global Health (MHIGH), effective May 1.

As NTM cases rise, the UAB Nontuberculous Mycobacterial (NTM) Program, led by Bryan Garcia, M.D., in partnership with German Henostroza, M.D., has formed a multidisciplinary team to provide individualized care, improve diagnosis, and enhance treatment outcomes for patients with NTM.

Just weeks after discharge, the patient is back at the hospital. This time, the infection has worsened, sepsis has set in, and emergency surgery is needed. A preventable outcome had intervention come sooner.

UAB is ranked No. 164 based on exceptional academic research portfolio and its overall global and regional reputation.

The funding will be used in two projects to combat growing syphilis rates in men and women in underserved areas.

By understanding the differences between these illnesses and utilizing convenient health care options, proactive steps can be taken to protect one’s health and support the health care system during this busy season.

The Stimulating Access to Research in Residency program, funded by the National Institute of Allergy and Infectious Diseases, is designed to help address the shortage of physician-scientists nationwide.

This past June, through a competitive review process, the NIH renewed their five-year grant to continue UAB’s Center for AIDS Research pivotal work.  

Study Information: Are you 18-60 years of age living with HIV, and want to be a part of a vaccine study? Is your viral load suppressed/undetectable?

Are you: A woman who has ever been in jail, prison, or on probation or parole? A woman who has used drugs?

The UAB neurosurgery team performed an emergency brain aspiration on Easton Fothergill after he was rushed to UAB Hospital with a large brain abscess.

Vern Bush, Kevin Davis and Brittany Martin are the first-quarter 2024 honorees of the UAB Values in Action Program. Nominations for second-quarter 2024 honorees are open through April 24.

Clinical trial findings from the LATITUDE study show promise in long-acting HIV treatment for patients who have long struggled with daily HIV oral medications.

Over its 28 years, this signature program has awarded grants totaling almost $60 million. Meet recipients and see how the HSF-GEF grants make UAB “a place where, if you have a good idea, you can find the support to make it a reality.”

Michael Mugavero, M.D., professor in the Division of Infectious Diseases, received HSF-GEF funding to launch the UAB Learning Health System project, where the people setting the research questions are not individual investigators with their own niche interests, “but the people in the trenches.”

Alabama is a hotbed for fungal diseases — which is why experts in treating and tracking problematic fungi gravitate to UAB. This is great news for Alabamians as killer fungi become a worldwide threat.

Scientists participating in the UAB Green Labs program explain why they take part, the biggest changes they made and how it has affected their labs.